ASA Triad, COVID-19, Temporomandibular Disorder
Conditions
Keywords
coronavirus, TMJ disorder, DC/TMD, ASA, Sars-CoV-2
Brief summary
There is evidence that CV-19 is associated with joint symptoms, but there are no specific data on the temporomandibular joint (TMJ). It is also known that the systemic health status can impact the immune system. Given all this, this study aimed to investigate the effect of CV-19 and systemic health status, as determined by the American Society of Anesthesiologists (ASA) Physical Status Classification System 12, on TMJ in patients with TMJ complaints using the DC/TMD scale.
Detailed description
This study investigates the effect of systemic status, according to American Society of Anesthesiologist (ASA), and COVID-19 on temporomandibular joint (TMJ) disorders using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) scale, shown to be valid for assessing TMJ disorders. The study included 76 patients who presented to our clinic with TMJ. Participants were divided into two groups: those with COVID-19 (CV-19, study group) and those without (non-CV-19, control group). These two groups were both further divided into subgroups according to ASA 1 and ASA 2 classification. Power analyses were performed using G\*Power software to determine the required number of patients. Groups were compared using the Symptom Questionnaire, a demographics survey, the Graded Chronic Pain Scale (GCPS), and the Jaw Functional Limitation Scale-20 (JFLS-20) of the DC/TMD. The statistical software program version 1.6.23 was used for statistical analysis. Although joint complaints were more common in ASA 2 patients with CV-19, the groups were not significantly different. The CV-19 ASA 2 group had the highest JFLS-20 score (mean: 1.3±1.5) and the non-CV-19 ASA 1 group had the lowest JFLS-20 score (mean: 0.7±0.8), but the differences were again not significant. Joint complaints were more common and more severe in ASA 2 patients with CV-19, albeit not with statistical significance. More studies are needed to better understand our results.
Interventions
OTHERDiagnostic Criteria for Temporomandibular Disorders (DC/TMD) scale
4 items of the DC/TMD scale were used in this study to evaluate the TMJ disorders. 1. Demographics Survey 2. DC/TMD Symptom Questionnaire (SQ) 3. Graded Chronic Pain Scale (GCPS) 4. Jaw Functional Limitation Scale-20 (JFLS-20)
Sponsors
Recep Tayyip Erdogan University Training and Research Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* applied to our clinic with TMJ discomfort * ASA 1 and ASA 2 patients
Exclusion criteria
* patients with acute CV-19 * Patients who are not in ASA 1 or ASA 2 classification * Patients under 18 year-old * Pregnants
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| DC/TMD scale - Demographics Survey | through study completion an average of 3 months | This survey consisted of 6 items concerning marital status, socioeconomic status, profession, education, and children. |
| DC/TMD scale - DC/TMD Symptom Questionnaire | through study completion an average of 3 months | This 14-item questionnaire aims to determine the duration and causes of pain and the associated symptoms. |
| DC/TMD scale - Graded Chronic Pain Scale | through study completion an average of 3 months | This 8-item scale is graded on a scale of 0-10 points. It includes 3 questions on pain intensity, 4 questions on function, and 1 question on the number of days with facial pain. The GCPS consists of two subscales. As the first subscale, Characteristic Pain Intensity is measured, where a score of ≥50 out of 100 possible points indicates high-intensity pain. The Interference Score is then calculated as the second subscale based on scores concerning interference in daily activities and work and the number of days with interference |
| DC/TMD scale - Jaw Functional Limitation Scale-20 | through study completion an average of 3 months | This scale consists of three subscales that address limitations of mastication, vertical mobility, and verbal and non-verbal communication. These three subscales are ideal for both research purposes and patient assessment of various functional limitations of the jaw. It is a global scale that consists of 20 items and the three aforementioned subscales (mastication, vertical mobility, and verbal and non-verbal communication) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| ASA 1 | through study completion an average of 3 months | American Society of Anesthesiologist 1 - systemically healthy patients |
| ASA 2 | through study completion an average of 3 months | American Society of Anesthesiologist 2 - A patient with mild systemic disease |
Countries
Turkey (Türkiye)
Outcome results
None listed